MO31-4 Phase 1b/2 trial of tucatinib+trastuzumab+/-chemotherapy or pembrolizumab in patients with metastatic HER2+ GI cancersKohei Shitara,Haeseong Park,Tanios Bekaii-Saab,Sunnie S. Kim,Suneel Kamath,Michael J. Pishvaian,Christopher Chen,David B. Zhen,Joal Mayor,Qianwen Tan,John H. StricklerAnnals of Oncology(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要